In contrast to GFAP, the magnitude of plasma and CSF NfL elevations is not higher in AD than in other dementia types and does not associate with amyloid or p-τ pathology at autopsy [192, 234, 250–252, 269, 300, 302]. The gene discussed is GFAP; the disease is Alzheimer disease.